ENCAPSULATION OF 5-AMINOSALICYLIC ACID INTO EUDRAGIT RS MICROSPHERES AND MODULATION OF THEIR RELEASE CHARACTERISTICS BY USE OF SURFACTANTS

被引:16
作者
WATTS, PJ [1 ]
DAVIES, MC [1 ]
MELIA, CD [1 ]
机构
[1] UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,NOTTINGHAM NG7 2RD,ENGLAND
关键词
MICROENCAPSULATION; EUDRAGIT RS; COLON DELIVERY; 5-AMINOSALICYLIC ACID; POROSITY;
D O I
10.1016/0168-3659(91)90008-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An emulsification-solvent evaporation technique has been used to produce microspheres containing 5-aminosalicylic acid from the acrylate-methacrylate copolymer, Eudragit(TM) RS. Two emulsifiers were used in the preparation procedure, either sodium dodecyl sulphate (SDS) or Tween 20, at a range of concentrations. Microspheres could be produced with both surfactants, although the yield using SDS was very low. The rate of drug release was found to be dependent on the concentration of emulsifier used to produce the microspheres. For example, microspheres produced using 0.25% w/v SDS released their encapsulated drug instantaneously on dissolution testing, whereas microspheres produced without surfactant provided prolonged release of drug (t50% > 360 min). Low temperature scanning electron microscopy revealed for these two systems that the differences in release resulted from different degrees of porosity in the microsphere drug-polymer matrix.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 18 条
[1]  
Kawata, Nakamura, Goto, Aoyama, Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen, Chem. Pharm. Bull., 34, pp. 2618-2623, (1986)
[2]  
Pongpaibul, Price, Whitworth, Preparation and evaluation of controlled-release indomethacin microspheres, Drug. Dev. Ind. Pharm., 10, pp. 1597-1616, (1984)
[3]  
Babay, Hoffman, Benita, Design and release kinetic pattern evaluation of indomethacin microspheres, Biomaterials, 9, pp. 482-488, (1988)
[4]  
Benita, Hoffman, Donbrow, Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model, J. Pharm. Pharmacol., 37, pp. 391-395, (1985)
[5]  
Goto, Kawata, Nakamura, Maekawa, Aoyama, Eudragit E, L and S (acrylic resins) microcapsules as pH-sensitive preparations of ketoprofen, J. Microencapsulation, 3, pp. 305-316, (1986)
[6]  
Handbook of Pharmaceutical Excipients, pp. 214-215, (1986)
[7]  
Jarnerot, Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease, Drugs, 37, pp. 73-86, (1989)
[8]  
Dew, Ryder, Evans, Evans, Rhodes, Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis, Br. J. Clin. Pharmacol., 16, pp. 185-187, (1983)
[9]  
Rasmussen, Bondesen, Hvidberg, Hansen, Bonder, Et al., 5-aminosalicylic acid in a slow release preparation: bioavailability, plasma level and excretion in humans, Gastroenterology, 83, pp. 1062-1070, (1982)
[10]  
Saffran, Kumar, Savariar, Burnham, Williams, Neckers, A new approach to the oral administration of insulin and other peptide drugs, Science, 233, pp. 1081-1084, (1986)